Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,998
New position
Shares Held
350
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#176
of 197 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Seneschal Advisors, LLC holds $91,853 across 12 Diagnostics & Research names. MYGN ranks #2 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
167 | $83,726 | |
| 2 | MYGN |
Myriad Genetics Inc
This page
|
350 | $1,998 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
1 | $1,277 | |
| 4 | WAT |
Waters Corp /De/
|
2 | $750 | |
| 5 | DGX |
Quest Diagnostics Inc
|
3 | $635 | |
| 6 | DHR |
Danaher Corp /De/
|
3 | $571 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2 | $560 | |
| 8 | NTRA |
Natera, Inc.
|
2 | $542 |
All Filings in MYGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,998 | 350 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||